BDBM790982 US20260034252, Compound RTX-1341S

SMILES CC(=O)NCCCCC(NC(=O)[C@@H](CCCCNC(=O)CCc1ccc(OC2=C(/C=C\C3=[N+](CCC[N+](C)(C)C)c4ccc(S(=O)(=O)[O-])cc4C3(C)C)CCC/C2=C\C=C2\N(CCC[N+](C)(C)C)c3ccc(S(=O)(=O)[O-])cc3C2(C)C)cc1)NC(=O)CCOCCOCCOCCNC(=O)COc1ccc2c(C(=O)NCC(=O)N3CCC[C@@H]3C#N)ccnc2c1)C(=O)O

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 790982   

TargetProlyl endopeptidase FAP(Human)
Ratio Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 790982BDBM790982(US20260034252, Compound RTX-1341S)
Affinity DataIC50: 0.100nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details US Patent